Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00637520 · ClinicalTrials.gov registry record
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 29
- Enrollment target
NCT00637520: Clinical Trial study, sponsored by Duke University.
NCT00637520 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00637520 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
We hypothesize that insulin resistance is characteristic of nonalcoholic fatty liver disease as compared to age, gender, non-diabetic BMI-matched control subjects, both healthy and those with non-cirrhotic, non-steatotic liver disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2007-07 |
| Est. Completion | 2017-04-13 |
Why NCT00637520 stopped before completion
NCT00637520 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00637520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00637520 about?
NCT00637520 is a clinical study titled "Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study". We hypothesize that insulin resistance is characteristic of nonalcoholic fatty liver disease as compared to age, gender, non-diabetic BMI-matched control subjects, both healthy and those with non-cirrhotic, non-steatotic liver disease.
What is the current status of trial NCT00637520?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2007-07. Estimated completion is 2017-04-13.
Who is sponsoring clinical trial NCT00637520?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia